Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 4Glioma 3Brain Neoplasms 3Neuroblastoma 2Astrocytoma 2Testicular Neoplasms 1Teratoma 1Spinal Cord Neoplasms 1Sarcoma 1Paraganglioma, Extra-Adrenal 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Oligodendroglioma 1Neurofibroma 1Neoplasms 1Meningioma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Medullary 1

Interventions

mirdametinib 2tipifarnib 1talimogene laherparepvec 1peginterferon alfa-2b 1nilotinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1Vincristine 1Temozolomide 1Talaporfin 1Sirolimus 1Restraint, Physical 1Ranibizumab 1Radiosurgery 1Photochemotherapy 1Neurofibromin 1 1Mn-PyC3A 1Imatinib Mesylate 1Everolimus 1Elasticity Imaging Techniques 1Deoxycholic Acid 1Cryotherapy 1Celecoxib 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibroma × Restraint, Physical × CNS × Clear all
NCT05957679 2026-02-12

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

Shengjing Hospital

Phase NA Recruiting
20 enrolled
CNS

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Meningioma, Neurofibroma, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡